Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 97

Sort by

Sort Order Select

Journal Articles

Single Cell Transcriptomics to Characterize the Features of Bone Marrow Natural Killer Cells in Different Relapse Modalities

Pier Rovatti, Marco Punta, Giorgio Orofino, Matteo Maria Naldini, Matteo Giovanni Carrabba, Massimo Bernardi, Jacopo Peccatori, Bernhard Gentner, Fabio Ciceri, Luca Vago, Cristina Toffalori

Blood (2024) 144 (Supplement 1): 929.

https://doi.org/10.1182/blood-2024-205896

Published: 2024

Journal Articles

Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant

Annalisa Tameni, Cristina Toffalori, Luca Vago

Blood (2024) 143 (26): 2710–2721.

https://doi.org/10.1182/blood.2023019962

Published: 2024

Journal Articles

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)

Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Massimo Bernardi, Carmen Di Grazia, Luca Vago, Giulia Rivoli, Lorenza Maria Borin, Patrizia Chiusolo, Luisa Giaccone, Maria Teresa Voso, Jan Philipp Bewersdorf, Olivier Nibourel, Marina Díaz-Beyá, Andres Jerez, Francisca Maria Hernandez, Kyra Velázquez Kennedy, Blanca Xicoy, Marta Ubezio, Alessia Campagna, Antonio Russo, Gabriele Todisco, Daniele Mannina, Stefania Bramanti, Matteo Zampini, Elena Riva, Marilena Bicchieri, Gianluca Asti, Filippo Viviani, Alessandro Buizza, Benedetta Tinterri, Andrea Bacigalupo, Alessandro Rambaldi, Francesco Passamonti, Fabio Ciceri, Victor Savevski, Armando Santoro, Najla H Al Ali, David A Sallman, Francesc Sole, Guillermo Garcia-Manero, Ulrich Germing, Shahram Kordasti, Valeria Santini, Guillermo Sanz, Wolfgang Kern, Anne Sophie Kubasch, Uwe Platzbecker, Maria Diez-Campelo, Jaroslaw P. Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M. Zeidan, Gastone Castellani, Rami S. Komrokji, Francesca Ieva, Matteo Giovanni Della Porta

Blood (2023) 142 (Supplement 1): 197.

https://doi.org/10.1182/blood-2023-182194

Published: 2023

Journal Articles

Inflammation Shapes the Transcriptional Landscape of the Bone Marrow Microenvironment in Post-Transplantation Leukemia Relapses

Pier Rovatti, Marco Punta, Giorgio Orofino, Matteo Maria Naldini, Matteo Giovanni Carrabba, Massimo Bernardi, Jacopo Peccatori, Bernhard Gentner, Fabio Ciceri, Luca Vago, Cristina Toffalori

Blood (2023) 142 (Supplement 1): 3578.

https://doi.org/10.1182/blood-2023-189715

Published: 2023

Journal Articles

Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation

Cristina Toffalori, Riccardo Bergamin, Alice Antonello, Anna Francesca Tortorelli, Giorgio Orofino, Matteo Cristante, Lucrezia Della Volpe, Salvatore Milite, Nicola Calonaci, Giorgia Gandolfi, Aurora Maurizio, Raffaella Greco, Gabriele Bucci, Dejan Lazarevic, Raffaella Di Micco, Giovanni Tonon, Fabio Ciceri, Giulio Caravagna, Luca Vago

Blood (2023) 142 (Supplement 1): 362.

https://doi.org/10.1182/blood-2023-188623

Published: 2023

Journal Articles

Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes

Blood (2022) 140 (Supplement 1): 1121–1124.

https://doi.org/10.1182/blood-2022-163634

Published: 2022

Journal Articles

Patients Reported Outcomes (PROs) Are Still Unsatisfactory Among AML Long-Term Survivors: The Impact of Chronic GvHD in a Prospective Study on 15 Years Transplant Activity

Maria Teresa Lupo-Stanghellini, Camilla Riva, Alessandro Bruno, Simona Piemontese, Raffaella Greco, Sarah Marktel, Sara Mastaglio, Elisabetta Xue, Daniela Clerici, Francesca Farina, Fabio Giglio, Elisa Diral, Luca Vago, Consuelo Corti, Andrea A. Assanelli, Massimo Bernardi, Jacopo Peccatori, Matteo Giovanni Carrabba, Fabio Ciceri

Blood (2022) 140 (Supplement 1): 10571–10572.

https://doi.org/10.1182/blood-2022-169554

Published: 2022

Journal Articles

Bispecifics need a mindful pause

Cristina Toffalori, Luca Vago

Blood (2022) 140 (10): 1056–1058.

https://doi.org/10.1182/blood.2022017726

Published: 2022

Journal Articles

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Blood (2022) 140 (10): 1167–1181.

https://doi.org/10.1182/blood.2022016082

Published: 2022

Includes: Supplemental data

Journal Articles

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

Blood (2021) 138 (25): 2655–2669.

https://doi.org/10.1182/blood.2020010477

Published: 2021

Includes: Supplemental data

Journal Articles

Therapy-Induced Senescence As an Anti-Cancer and Immune-Stimulatory Strategy

Diego Gilioli, Simona Fusco, Kety Giannetti, Valentina Gambacorta, Teresa Tavella, Carmine Liberatore, Stefano Beretta, Martin Schönlein, Ivan Merelli, Fabio Ciceri, Luca Vago, Clemens A. Schmitt, Raffaella Di Micco

Blood (2021) 138 (Supplement 1): 4419.

https://doi.org/10.1182/blood-2021-152618

Published: 2021

Journal Articles

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Pier Edoardo Rovatti, MD, Laura Zito, MSc, Eleonora Draghi, MSc, Monika Herrmann, PhD, Anetta Marcinek, MSc, Bettina Brauchle, MSc, Cesare Covino, MSc, Mattia Di Bono, MSc, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Karl-Peter Hopfner, PhD, Cristina Toffalori, PhD, Fabio Ciceri, MD, Marion Subklewe, MD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 513.

https://doi.org/10.1182/blood-2019-126641

Published: 2019

Journal Articles

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Valentina Gambacorta, MSc, Daniela Gnani, PhD, Laura Zito, MSc, Stefano Beretta, PhD, Lucia Zanotti, PhD, Oliveira Giacomo, PhD, Davide Cittaro, PhD, Ivan Merelli, PhD, Fabio Ciceri, MD, Raffaella Di Micco, PhD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 514.

https://doi.org/10.1182/blood-2019-127395

Published: 2019

Journal Articles

Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms

Elisa Sala, MD, Francesca Biavasco, MD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Donatella Biancolini, PhD, Elena Antonini, MSc, Matteo Giovanni Carrabba, MD, Bernhard Gentner, MD, Cristina Tresoldi, MSc, Massimo Bernardi, MD, Dejan Lazarevic, MD, Giovanni Tonon, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 511.

https://doi.org/10.1182/blood-2019-124725

Published: 2019

Journal Articles

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2019) 134 (Supplement_1): 3281.

https://doi.org/10.1182/blood-2019-125369

Published: 2019

Journal Articles

Mechanisms of immune escape after allogeneic hematopoietic cell transplantation

Robert Zeiser, Luca Vago

Blood (2019) 133 (12): 1290–1297.

https://doi.org/10.1182/blood-2018-10-846824

Published: 2019

Journal Articles

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Lucia Zanotti, PhD, Gabriele Bucci, PhD, Francesco Santaniello, Cristina Toffalori, Donatella Biancolini, PhD, Ettore Zapparoli, Laura Zito, Matteo Giovanni Carrabba, MD, Friedrich Stoelzel, Martin Bornhäuser, Massimo Bernardi, MD, Jacopo Peccatori, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, Giovanni Tonon, MD PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2018) 132 (Supplement 1): 819.

https://doi.org/10.1182/blood-2018-99-111769

Published: 2018

Journal Articles

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Francesco Manfredi, MD, Maddalena Noviello, PhD, Eliana Ruggiero, PhD, Tommaso Perini, MD, Giacomo Oliveira, PhD, Filippo Cortesi, PhD, Pantaleo De Simone, MD, Cristina Toffalori, Valentina Gambacorta, MSc, Raffaella Greco, MD, Jacopo Peccatori, Monica Casucci, PhD, Giulia Casorati, PhD, Paolo Dellabona, MD PhD, Nicoletta Cieri, MD PhD, Attilio Bondanza, MD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2018) 132 (Supplement 1): 2028.

https://doi.org/10.1182/blood-2018-99-118104

Published: 2018

Journal Articles

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

Francesca Lorentino, Nicoletta Sacchi, PhD BSc, Elena Oldani, MSc, Valeria Miotti, Alessandra Picardi, Anna Maria Gallina, Paolo Bernasconi, Riccardo Saccardi, MD, Lucia Farina, MD, Fabio Benedetti, Francesca Patriarca, MD, Michela Cerno, Benedetto Bruno, Alessandro Rambaldi, MD, Fabio Ciceri, MD, Katharina Fleischhauer, Luca Vago, MD PhD, Francesca Bonifazi

Blood (2018) 132 (Supplement 1): 482.

https://doi.org/10.1182/blood-2018-99-115216

Published: 2018

Journal Articles

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Blood (2018) 132 (Supplement 1): 4642.

https://doi.org/10.1182/blood-2018-99-114486

Published: 2018

NARROW

Single Cell Transcriptomics to Characterize the Features of Bone Marrow Natural Killer Cells in Different Relapse Modalities

Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)

Inflammation Shapes the Transcriptional Landscape of the Bone Marrow Microenvironment in Post-Transplantation Leukemia Relapses

Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation

Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes

Patients Reported Outcomes (PROs) Are Still Unsatisfactory Among AML Long-Term Survivors: The Impact of Chronic GvHD in a Prospective Study on 15 Years Transplant Activity

Bispecifics need a mindful pause

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

Therapy-Induced Senescence As an Anti-Cancer and Immune-Stimulatory Strategy

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Mechanisms of immune escape after allogeneic hematopoietic cell transplantation

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only